It did, I just meant this is the most important because if successful, this is when big pharma comes a knockin. They can still buy us for cheap, but with a ton of risk eliminated. If they buy as after 2B results, they know they have a great chance at passing 3.
Best of luck, exciting times. I'm hearing April 16th as a possible data read out date.
It did, I just meant this is the most important because if successful, this is when big pharma comes a knockin. They can still buy us for cheap, but with a ton of risk eliminated. If they buy as after 2B results, they know they have a great chance at passing 3.
Best of luck, exciting times. I'm hearing April 16th as a possible data read out date.
Yes - phase 2b is for efficacy of various dosage by comparison. It allows companies to lock the final dosage. The phase 3 is really large scale test to confirm selected dosage.
With this drug no side effect and high efficacy will be key.
This is the 5 week from the last communications. Last week they would have taken final reading. We could get results as early as 13th April
Market Data 
Markets 
AI
